Controls Pvt. Ltd.
A-21, M.I.D.C Industrial Area,
Street # 3, Andheri East.
Mumbai - 400 093, India.
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (“FDF”) and active pharmaceutical ingredients (“APIs”). Natco entrusts Klenzaids with projects where containment of product and personnel is extremely critical. Klenzaids provides customized solutions for such potent molecules and executes projects for Industry majors like Natco, Frezenius Kabi, Teva, Dr. Reddys Lab, Hetero Drugs, Aurobindo, Sanofi, Bharat Biotech etc
Oral solid formulations under maximum containment.
International safety mandates such as OSHA/NIOSH, Inventor safety and quality strategies, Occupational Toxologists such as Safebridge Consultants and peer industry practices are all taken into consideration when working on such a project.
Imperatives are global quality and safety assurance, functional ease despite contained settings, complete hermetics, clean-in-place repeatability to eventually produce a life saving oncological formulation in capsules at costs that are affordable by the masses. Natco prides itself in such forays and continues to stay steady on this path lending a strong arm to India’s push to the global curse of cancer.
Natco experts in synthetic chemistry.
Natco have been working with molecules of complexity & lifesaving power. Synthetically challenging therapeutics, innovative dosage forms, R&D in Nanotechnology set Natco apart from many companies and Klenzaids has always been involved in Natco’s facilities.
Klenzaids continues working with Natco on API, OSD, Liquid Parenteral, Capsulation (as in this case study presentation) partnering in India’s success in generating a local Anti-Cancer support Infrastructure.